| Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397) |
|---|
| 01/24/2007 | CN1296370C Anti plant virus agricultural cytosin peptidechycin, and its preparing process |
| 01/24/2007 | CN1296365C Imidazolinylmethyl aralkylsulfonamides |
| 01/24/2007 | CN1296354C Pharmaceutically active pyrrolidine derivatives as BAX inhibitors |
| 01/23/2007 | US7167801 Method of identifying potential inhibitors of human papillomavirus protein E2 using x-ray atomic coordinates |
| 01/23/2007 | US7166659 Substituted 5-aryl-2-(2-hydroxyphenyl)-2H-benzotriazole UV absorbers, compositions stabilized therewith and process for preparation thereof |
| 01/23/2007 | US7166635 3-imino-2-indolones for the treatment of depression and/or anxiety |
| 01/23/2007 | US7166629 Aminoindazole derivatives as medicaments and pharmaceutical compositions including them |
| 01/23/2007 | US7166617 Cyclic amide derivatives |
| 01/23/2007 | US7166614 CCR-2 modulators; INFLAMMATORY, IMMUNOREGULATORY, ALLERGIC, AND AUTOIMMUNE DISORDERS AND DISEASES |
| 01/23/2007 | US7166609 Osteoarthritis; periodontal disease; antiarthritic agents |
| 01/23/2007 | US7166598 Piperazine derivatives |
| 01/23/2007 | US7166589 Quinoline derivatives |
| 01/23/2007 | US7166586 Sulfonamide lactam inhibitors of FXa and method |
| 01/23/2007 | US7166293 Anticancer agents; antitumor agents; cardiovascular diosrders; antiinflammatory agents |
| 01/23/2007 | CA2239968C Pyrimidine derivatives and guanine derivatives, and their use in treating tumour cells |
| 01/23/2007 | CA2192186C Process for the preparation of chiral intermediates useful for the synthesis of antifungal agents |
| 01/18/2007 | WO2007008895A1 Kinase inhibitors |
| 01/18/2007 | WO2007007910A1 Heterocycle-substituted benzimidazole derivative |
| 01/18/2007 | WO2007007886A1 An oxime derivative and preparations thereof |
| 01/18/2007 | WO2007007778A1 Benzoimidazole compound capable of inhibiting prostaglandin d synthetase |
| 01/18/2007 | WO2007007688A1 3,5-diamino-1,2,4-triazole derivative |
| 01/18/2007 | WO2007007072A1 5-htx modulators |
| 01/18/2007 | WO2007007041A1 Heteroaryl benzamide derivatives for use as glk activators in the treatment of diabetes |
| 01/18/2007 | WO2007006928A1 N-[(4,5-diphenylpyrimidin-2-yl)methyl]amine derivatives, the preparation thereof and their therapeutic use |
| 01/18/2007 | WO2007006739A1 Benzoheterocyclylethylcarboxamide derivatives |
| 01/18/2007 | WO2006113140A3 Novel compounds useful for bradykinin b1 receptor antagonism |
| 01/18/2007 | WO2006110447A3 Pyrimidine derivatives and their use in the treatment of cancer |
| 01/18/2007 | WO2006102097A3 Synthesis of avrainvillamide, stephacidin b, and analogues thereof |
| 01/18/2007 | WO2005070893A3 Azadecalin glucocorticoid receptor modulators |
| 01/18/2007 | US20070015870 Sulfoxides or sulfones grafted onto polymers |
| 01/18/2007 | US20070015823 Ambruticin VS compounds |
| 01/18/2007 | US20070015821 Synthesis and complete stereochemical assignment of psymberin/irciniastatin for use as antitumor compounds |
| 01/18/2007 | US20070015820 1,3-Diacetyl-8-hydroxy-2-(7-hydroxychromanon-3-yl)-9H-xanthen-9-ones; obtained from a culture of the Penicillium strain SPF-3059; prevents growth cone collapse |
| 01/18/2007 | US20070015817 4-((4-(2-pyrrolidinylethoxy)phenyl)methyl)-3-(4-(trifluoromethyl)phenyl)-7-hydroxychromen-2one, pharmaceutically acceptable salts thereof and methods of use therewith |
| 01/18/2007 | US20070015802 Inhibitors of cyclin dependent kinases and their use |
| 01/18/2007 | US20070015799 Glyoxalase inhibitors |
| 01/18/2007 | US20070015779 [1-(4-pyrimidinyl, 5-pyrrolyl, or 4-pyridinyl)-3,5-disubstituted-1H-pyrazol-4-yl]dihydroxyalkanoic acids and 6-alkyl-gamma-hydroxyvalerolactones; antiinflammatory agents; carciovascular disorders; p38 map kinase inhibitors |
| 01/18/2007 | US20070015775 Heterocyclic compounds |
| 01/18/2007 | US20070015774 Quinazoline derivatives useful in cancer treatment |
| 01/18/2007 | US20070015769 Use of 5ht4 receptor antagonists in the prophylaxis or treatment of certain cardiovascular conditions |
| 01/18/2007 | US20070015764 Inhibits hepatitus virus replication; useful in therapeutic and prophylactic treatment of hepatitis C virus |
| 01/18/2007 | US20070015755 Novel compounds and compositions as protease inhibitors |
| 01/18/2007 | US20070015730 [4-(tert-butyldimethylsilanyloxy)-3-oxobutyl]methylcarbamic acid tert-butyl ester; (R)-6,8-difluoro-3,4-dihydro-2H-1-benzopyran-3-amine; for the treatment of cardiovascular disorders such as hypertension and chronic heart failure |
| 01/18/2007 | CA2614597A1 Novel 2,4-dianilinopyrimidine derivatives, the preparation thereof, their use as medicaments, pharmaceutical compositions and, in particular, as ikk inhibitors |
| 01/18/2007 | CA2614544A1 Heterocycle-substituted benzimidazole derivative |
| 01/18/2007 | CA2614147A1 Benzoimidazole compound capable of inhibiting prostaglandin d synthetase |
| 01/18/2007 | CA2602389A1 Kinase inhibitors |
| 01/17/2007 | EP1743885A2 TNF-Alpha Produktion Hemmer zur Behandlung von Autoimmunerkrankungen |
| 01/17/2007 | EP1742942A1 Phenylthioacetic acid derivatives and use thereof |
| 01/17/2007 | EP1742941A1 Novel saperconazole crystalline forms and related processes, pharmaceutical compositions and methods |
| 01/17/2007 | EP1742940A1 N-[6-(4-morpholinyl)-3-pyridinyl]-2-(tetrahydro-2h-pyran-4-yl)-n-[(1-{[phenyl]methyl}-4-piperidinyl)methyl] acetamide derivatives and related compounds as glyt1 transport inhibitors for the treatment of neurological disorders such as schizophrenia |
| 01/17/2007 | EP1742939A2 Novel alkyne compounds exhibiting an mch antagonistic effect and drugs containing said compounds |
| 01/17/2007 | EP1742935A1 Polycyclic pyrazines as potassium ion channel modulators |
| 01/17/2007 | EP1742934A2 Piperidine derivatives as modulators of chemokine receptor ccr5 |
| 01/17/2007 | EP1742920A2 Naphthalimide derivatives for the treatment of cancer |
| 01/17/2007 | EP1742919A2 Tetrahydropyranyl cyclopentyl 1-substituted and 1,1-disubstituted tetrahydroisoquinoline modulators of chemokine receptor activity |
| 01/17/2007 | EP1742918A1 Lxr receptor modulators |
| 01/17/2007 | EP1742916A1 Phenyl compounds and their use in the treatment of conditions mediated by the action of pge2 at the ep1 receptor |
| 01/17/2007 | EP1742915A2 Tetrahydropyranyl cyclopentyl tetrahy-dropyridopyridine modulators of chemokine receptor activity |
| 01/17/2007 | EP1742912A1 Novel androgens |
| 01/17/2007 | EP1742707A2 Treatment of cns disorders using cns target modulators |
| 01/17/2007 | EP1742634A1 Polycyclic pyrimidines as potassium ion channel modulators |
| 01/17/2007 | EP1401575B1 Hydroxylation of beta-dicarbonyls with zirconium catalysts |
| 01/17/2007 | EP1268444B1 2,4-di(hetero-)arylamino(-oxy)-5-substituted pyrmidines as antineoplastic agents |
| 01/17/2007 | CN1898244A Triazole derivatives as vasopressin antagonists |
| 01/17/2007 | CN1898234A Substituted cyclic hydroxamates as inhibitors of matrix metalloproteinases |
| 01/17/2007 | CN1898233A Process for the manufacture of the calcium salt of rosuvatatin (e)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl](3r,5s)-3,5-dihydroxyhept-6-enoic acid and crystallin |
| 01/17/2007 | CN1898216A Amide derivatives |
| 01/17/2007 | CN1898214A Dicationic triaryl analogs as anti-protozoan agents |
| 01/17/2007 | CN1898210A 2-pyridinylethylcarboxamide derivatives and their use as fungicides |
| 01/17/2007 | CN1898209A Pyridine carboxylic acid derivatives as glucokinase modulators |
| 01/17/2007 | CN1898208A Amide derivative and medicine |
| 01/17/2007 | CN1898205A Indolinone derivatives and their use in treating disease-states such as cancer |
| 01/17/2007 | CN1897948A Alkoxy substituted imidazoquinolines |
| 01/17/2007 | CN1897941A Alkylamino, arylamino, and sulfonamido cyclopentyl amide modulators of chemokine receptor activity |
| 01/17/2007 | CN1897928A Novel alanyl-amino peptidase inhibitors for functionally influencing different cells and treating immunological, inflammatory, neuronal, and other diseases |
| 01/17/2007 | CN1896070A 2- and 2,5-substituted phenylketo-enols |
| 01/17/2007 | CN1295221C Substituted heterocyclic compounds |
| 01/17/2007 | CN1295217C New asymmetric diaryl-methylamine intermediates for the preparation of diarylmethylpiperazines derivatives |
| 01/17/2007 | CN1295216C Molindone derivatives and use for preparing antineoplastic medicine thereof |
| 01/16/2007 | US7164027 Aralkyl ester soft drugs |
| 01/16/2007 | US7163957 anti-psychotic; selectively interact with the dopaminergic receptors of the D2/D3 subtypes and the serotoninergic receptors of the 5-HT1A subtype at the level of which they behave as antagonists and agonists, respectively |
| 01/16/2007 | US7163943 e.g., 6-(3-Chloro-4-methoxy-phenoxy)-N-cycloheptyl-N'-methyl-N'-(1-methyl-piperidin-4-yl)-[1,3 ,5]triazine-2,4-diamine; inhibit or block glycated protein produced induction of the signaling-associated inflammatory response in endothelial cells and inhibit smooth muscle proliferation. |
| 01/16/2007 | US7163937 Cyclic derivatives as modulators of chemokine receptor activity |
| 01/16/2007 | CA2219742C N-heteroaryl-pyridinesulfonamide derivatives and their use as endothelin antagonists |
| 01/16/2007 | CA2218981C Radicicol derivatives |
| 01/11/2007 | WO2007005404A1 AMINO-5-(6-MEMBERED)HETEROARYLIMIDAZOLONE COMPOUNDS AND THE USE THEREOF FOR ß-SECRETASE MODULATION |
| 01/11/2007 | WO2007005366A1 AMlNO-5-(5-MEMBERED)HETEROARYLIMIDAZOLONE COMPOUNDS AND THE USE THEREOF FOR β-SECRETASE MODULATION |
| 01/11/2007 | WO2007005000A1 Method of synthesis of imidazole-amino acid derivatives and related compounds |
| 01/11/2007 | WO2007003934A2 17beta-hydr0xyster0id dehydrogenase type 3 (17beta-hsd3 ) inhibitors |
| 01/11/2007 | WO2005105776A8 Arylsulfonyl benzodioxanes useful for modulation the 5-ht6 receptor, the 5-ht2areceptor or both |
| 01/11/2007 | US20070010671 Novel quinazoline derivatives and methods of treatment related to the use thereof |
| 01/11/2007 | US20070010668 antineoplastic/antimitotic agents; inhibit proliferation of the cell; breast cancer, colon cancer, lung cancer, prostate cancer, lymphoma, leukemia, endometrial cancer, melanoma; Polo-like kinase inhibitors; 2-({5-nitro-2-[(3,4,5-trimethoxyphenyl)amino]pyrimidin-4-yl}amino)benzoic acid hydrochloride |
| 01/11/2007 | US20070010563 Novel methods for the treatment of inflammatory diseases |
| 01/11/2007 | US20070010559 Indole derivatives for use as chemical uncoupler |
| 01/11/2007 | US20070010558 Opioid receptor antagonists |
| 01/11/2007 | US20070010557 Novel amides useful for treating pain |
| 01/11/2007 | US20070010551 Quinoline derivatives as neutrophil elastase inhibitors and their use |
| 01/11/2007 | US20070010542 Therapeutic or prophylactic agent for acid-related diseases, having an excellent inhibitory effect against gastric acid secretion, an excellent effect of maintaining the inhibitory effect against gastric acid secretion, thereby maintaining intragastric pH high for a long time, bactericidal agent |
| 01/11/2007 | US20070010534 Novel compounds |